These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2163309

  • 1. Evidence for calcitonin receptor heterogeneity: binding studies with nonhelical analogs.
    Nakamuta H, Orlowski RC, Epand RM.
    Endocrinology; 1990 Jul; 127(1):163-9. PubMed ID: 2163309
    [Abstract] [Full Text] [Related]

  • 2. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
    Houssami S, Findlay DM, Brady CL, Martin TJ, Epand RM, Moore EE, Murayama E, Tamura T, Orlowski RC, Sexton PM.
    Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
    [Abstract] [Full Text] [Related]

  • 3. Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions.
    Stroop SD, Nakamuta H, Kuestner RE, Moore EE, Epand RM.
    Endocrinology; 1996 Nov; 137(11):4752-6. PubMed ID: 8895343
    [Abstract] [Full Text] [Related]

  • 4. Biologically active, derivatizable salmon calcitonin analog: design, synthesis, and applications.
    D'Santos CS, Nicholson GC, Moseley JM, Evans T, Martin TJ, Kemp BE.
    Endocrinology; 1988 Sep; 123(3):1483-8. PubMed ID: 2841096
    [Abstract] [Full Text] [Related]

  • 5. [Centrally and peripherally induced anorectic actions of salmon calcitonin (sCT) in rats: separation of its novel derivative [Gly8]-sCT].
    Nakamuta H, Koida M, Ogawa Y, Orlowski RC.
    Nihon Yakurigaku Zasshi; 1987 Apr; 89(4):191-5. PubMed ID: 3038715
    [Abstract] [Full Text] [Related]

  • 6. A noncyclical analog of salmon calcitonin (N alpha-propionyl Di-Ala1,7,des-Leu19 sCT) retains full potency without inducing anorexia in rats.
    Yates AJ, Gutierrez GE, Garrett IR, Mencel JJ, Nuss GW, Schreiber AB, Mundy GR.
    Endocrinology; 1990 Jun; 126(6):2845-9. PubMed ID: 2351097
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and utility of novel benzophenone-containing calcitonin analogs for photoaffinity labeling the calcitonin receptor.
    Suva LJ, Flannery MS, Caulfield MP, Findlay DM, Jüppner H, Goldring SR, Rosenblatt M, Chorev M.
    J Pharmacol Exp Ther; 1997 Nov; 283(2):876-84. PubMed ID: 9353409
    [Abstract] [Full Text] [Related]

  • 8. Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts.
    Wada S, Udagawa N, Nagata N, Martin TJ, Findlay DM.
    Endocrinology; 1996 Mar; 137(3):1042-8. PubMed ID: 8603572
    [Abstract] [Full Text] [Related]

  • 9. Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor.
    Samura A, Wada S, Suda S, Iitaka M, Katayama S.
    Endocrinology; 2000 Oct; 141(10):3774-82. PubMed ID: 11014233
    [Abstract] [Full Text] [Related]

  • 10. Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase Alpha-mediated mechanism.
    Wada S, Udagawa N, Nagata N, Martin TJ, Findlay DM.
    Endocrinology; 1996 Jan; 137(1):312-20. PubMed ID: 8536630
    [Abstract] [Full Text] [Related]

  • 11. Biological activities and receptor interactions of des-Leu16 salmon and des-Phe16 human calcitonin.
    Findlay DM, Michelangeli VP, Orlowski RC, Martin TJ.
    Endocrinology; 1983 Apr; 112(4):1288-91. PubMed ID: 6299689
    [Abstract] [Full Text] [Related]

  • 12. Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells.
    Wada S, Martin TJ, Findlay DM.
    Endocrinology; 1995 Jun; 136(6):2611-21. PubMed ID: 7750484
    [Abstract] [Full Text] [Related]

  • 13. Effects of continuous calcitonin treatment on osteoclasts derived from cocultures of mouse marrow stromal and spleen cells.
    Liu BY, Wang JT, Leu JS, Chiang CP, Hsieh CC, Kwan HW.
    J Formos Med Assoc; 2000 Feb; 99(2):140-50. PubMed ID: 10770029
    [Abstract] [Full Text] [Related]

  • 14. Human placental calcitonin receptors.
    Nicholson GC, D'Santos CS, Evans T, Moseley JM, Kemp BE, Michelangeli VP, Martin TJ.
    Biochem J; 1988 Mar 15; 250(3):877-82. PubMed ID: 2839149
    [Abstract] [Full Text] [Related]

  • 15. Expression of a novel receptor for the calcitonin peptide family and a salmon calcitonin-like peptide in the alpha-thyrotropin thyrotroph cell line.
    Hanna FW, Smith DM, Johnston CF, Akinsanya KO, Jackson ML, Morgan DG, Bhogal R, Buchanan KD, Bloom SR.
    Endocrinology; 1995 Jun 15; 136(6):2377-82. PubMed ID: 7750458
    [Abstract] [Full Text] [Related]

  • 16. Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors.
    Hilton JM, Dowton M, Houssami S, Sexton PM.
    J Endocrinol; 2000 Jul 15; 166(1):213-26. PubMed ID: 10856900
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of rat kidney calcitonin receptors by salmon calcitonin infusion evidenced by autoradiography.
    Bouizar Z, Rostène WH, Milhaud G.
    Proc Natl Acad Sci U S A; 1987 Aug 15; 84(15):5125-8. PubMed ID: 3037535
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biologically active calcitonin analogs which have minimal interactions with phospholipids.
    Epand RM, Epand RF, Orlowski RC.
    Biochem Biophys Res Commun; 1988 Apr 15; 152(1):203-7. PubMed ID: 3358761
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.